These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 37517421)

  • 1. A promising candidate for a universal influenza vaccine.
    Isakova-Sivak I; Rudenko L
    Lancet Infect Dis; 2023 Dec; 23(12):1327-1329. PubMed ID: 37517421
    [No Abstract]   [Full Text] [Related]  

  • 2. A universal problem.
    Hoag H
    Nat Med; 2013 Jan; 19(1):12-4. PubMed ID: 23295998
    [No Abstract]   [Full Text] [Related]  

  • 3. Novel universal influenza virus vaccine approaches.
    Krammer F
    Curr Opin Virol; 2016 Apr; 17():95-103. PubMed ID: 26927813
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The future of haemagglutinin stalk-based universal influenza vaccines.
    Isakova-Sivak I; Rudenko L
    Lancet Infect Dis; 2022 Jul; 22(7):926-928. PubMed ID: 35461523
    [No Abstract]   [Full Text] [Related]  

  • 5. Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity.
    Wheatley AK; Kent SJ
    Expert Rev Vaccines; 2015; 14(9):1227-39. PubMed ID: 26175180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A single-shot vaccine approach for the universal influenza A vaccine candidate M2e.
    Kavishna R; Kang TY; Vacca M; Chua BYL; Park HY; Tan PS; Chow VT; Lahoud MH; Alonso S
    Proc Natl Acad Sci U S A; 2022 Mar; 119(13):e2025607119. PubMed ID: 35320040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preparing for the Next Influenza Pandemic: The Development of a Universal Influenza Vaccine.
    Crank MC; Mascola JR; Graham BS
    J Infect Dis; 2019 Apr; 219(Suppl_1):S107-S109. PubMed ID: 30715413
    [No Abstract]   [Full Text] [Related]  

  • 8. A Bivalent Heterologous DNA Virus-Like-Particle Prime-Boost Vaccine Elicits Broad Protection against both Group 1 and 2 Influenza A Viruses.
    Jiang W; Wang S; Chen H; Ren H; Huang X; Wang G; Chen Z; Chen L; Chen Z; Zhou P
    J Virol; 2017 May; 91(9):. PubMed ID: 28179535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation live-attenuated influenza vaccine platforms.
    Ullah S; Ross TM
    Expert Rev Vaccines; 2022 Aug; 21(8):1097-1110. PubMed ID: 35502639
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
    Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
    PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Self-assembling protein nanoparticles: a promising tool against lethal influenza?
    Burkhard P; Karch CP
    Nanomedicine (Lond); 2017 Jul; 12(13):1529-1531. PubMed ID: 28621581
    [No Abstract]   [Full Text] [Related]  

  • 12. Universal influenza virus vaccines and therapeutic antibodies.
    Nachbagauer R; Krammer F
    Clin Microbiol Infect; 2017 Apr; 23(4):222-228. PubMed ID: 28216325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Return of inactivated whole-virus vaccine for superior efficacy.
    Furuya Y
    Immunol Cell Biol; 2012 Jul; 90(6):571-8. PubMed ID: 21844883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice.
    Rowell J; Lo CY; Price GE; Misplon JA; Epstein SL; Garcia M
    Vaccine; 2018 Feb; 36(7):1008-1015. PubMed ID: 29249542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus.
    Morgan SB; Hemmink JD; Porter E; Harley R; Shelton H; Aramouni M; Everett HE; Brookes SM; Bailey M; Townsend AM; Charleston B; Tchilian E
    J Immunol; 2016 Jun; 196(12):5014-23. PubMed ID: 27183611
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of Influenza A Virus Transmission in Mice by a Universal Intranasal Vaccine Candidate is Long-Lasting and Does Not Require Antibodies.
    Price GE; Lo CY; Misplon JA; Epstein SL
    J Virol; 2022 Jun; 96(12):e0032022. PubMed ID: 35638848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine.
    Tchilian E; Holzer B
    Viruses; 2017 May; 9(5):. PubMed ID: 28475122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A one-size-fits-all flu vaccine?
    Kaiser J
    Science; 2006 Apr; 312(5772):380-2. PubMed ID: 16627732
    [No Abstract]   [Full Text] [Related]  

  • 19. Computationally Optimized Broadly Reactive H2 HA Influenza Vaccines Elicited Broadly Cross-Reactive Antibodies and Protected Mice from Viral Challenges.
    Reneer ZB; Jamieson PJ; Skarlupka AL; Huang Y; Ross TM
    J Virol; 2020 Dec; 95(2):. PubMed ID: 33115871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. rM2e-ΔPly protein immunization induces protection against influenza viruses and its co-infection with Streptococcus pneumoniae in mice.
    Guo T; Xiao J; Li L; Xu W; Yuan Y; Yin Y; Zhang X
    Mol Immunol; 2022 Dec; 152():86-96. PubMed ID: 36306645
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.